Skip to main content
. 2014 Jun 19;7:1025–1032. doi: 10.2147/OTT.S40527

Figure 1.

Figure 1

OCEANS study.

Note: *Up to ten cycles in case of ongoing response.

Abbreviations: BV, bevacizumab 15 mg/m2; CI, confidence interval; CG, carboplatin AUC 4 (area under the curve), gemcitabine 1,000 mg/m2; GIP, gastrointestinal perforation; HR, hazard ratio; ORR, overall response rate; PD, progression disease; PFS, progression-free survival; Pl, placebo; PS, Eastern Cooperative Oncology Group Performance Status; pts, patients; vs, versus; OCEANS, Ovarian Cancer Study Comparing Efficacy and Safety of Chemotherapy and Anti-aging Therapy in Platinum-Sensitive Recurrent Disease.